Echtzeit-Aktienkurs PRECIGEN INC.
Bid:
Ask:
Echtzeit-Chart der PRECIGEN INC. Aktie
Fundamentaldaten der PRECIGEN INC. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 [USD] | 160,57 Mio. | -536,23 Mio. | -509,34 Mio. | -3,93 | - | - | - |
| 2017 [USD] | 230,98 Mio. | -129,70 Mio. | -117,02 Mio. | -0,98 | - | - | - |
| 2016 [USD] | 190,93 Mio. | -194,15 Mio. | -186,61 Mio. | -1,58 | - | - | - |
| 2015 [USD] | 173,61 Mio. | -86,98 Mio. | -84,49 Mio. | -0,76 | - | - | - |
| 2014 [USD] | 71,93 Mio. | -85,72 Mio. | -81,82 Mio. | -0,83 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der PRECIGEN INC. Aktie
Intrexon Corp. operates as a biotechnology company. The company engages in the field of synthetic biology, which is an emerging discipline that applies engineering principles to biological systems. It designs, builds and regulates gene programs, which are DNA sequences that consist of key genetic components by using its suite of proprietary and complementary technologies. The company offers UltraVector proprietary technology platforms for the design, creation, modification, and regulation of complex gene programs and cellular systems at commercial scale; and RTS technology, which provides inducible control over the level and timing of gene expression and is part of an UltraVector library of various diverse modular genetic components. Intrexon was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.